Natco Pharma Share Price (NATCOPHARM)
as on
| Source : NSE
Natco Pharma Stock Performance
as on August 26, 2025 at 4:01 PM IST
Day's Low
Day's High
₹853.6₹875.35
0.19%
Downside
2.35%
Upside
52 Week's Low
52 Week's High
₹726.8₹1,63915.02%
Downside
91.64%
Upside
| Market Stats | |
| Previous Close | ₹874.85 |
| Open | ₹874.95 |
| Volume | 3.80L |
| Upper Circuit | ₹1,049.80 |
| Lower Circuit | ₹699.90 |
| Day's Low | ₹853.6 |
| Day's High | ₹875.35 |
| 52 Week Low | ₹726.8 |
| 52 Week High | ₹1,639 |
| Returns % | |
| 1 Month Return | -9.14 % |
| 3 Month Return | -2.66 % |
| 1 Year Return | -45.31 % |
| 3 Year Return | + 39 % |
| 5 Year Return | + 5.33 % |
Natco Pharma Stock Fundamentals & Key Indicators
Check Natco Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹15,318.37 Cr
Return on Equity (ROE)
25.38
PE Ratio (TTM)
9.02
Return on capital employed (ROCE)
28.58
Industry PE ratio
43.96
Beta (LTM)
0.88
P/B Ratio
3.05
Dividend Yield
1
PEG Ratio
2.64
Quarterly Earnings Growth YOY
-28.15
EPS (TTM)
77.56
Sector
Pharmaceuticals
Book Value
326.99
Technical Analysis
Bearish
View Technical Analysis
Natco Pharma Stock's Interest Amongst Investors
Natco Pharma Stock Valuation
Track how Natco Pharma P/E has moved over time to understand its valuation trends.
Natco Pharma in the last 5 years
Lowest (7.09x)
April 9, 2025
Today (9.02x)
August 26, 2025
Industry (43.96x)
August 26, 2025
Highest (90.32x)
April 6, 2022
Today’s Price to Earnings Ratio: 9.02x
Natco Pharma Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Natco Pharma.
based on 11 analysts
30.00%
Buy
20.00%
Hold
50.00%
Sell
50% of analysts recommend a 'HOLD' rating for Natco Pharma. Average target price of ₹982.64
Source: S&P Global Market Intelligence
Natco Pharma Share Price Target
Get share price movements and forecasts by analysts on Natco Pharma.
Natco Pharma price forecast by 11 analysts
Upside of14.90%
High
₹1480
Target
₹982.64
Low
₹712
Natco Pharma target price ₹982.64, a slight upside of 14.9% compared to current price of ₹855.25. According to 11 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Natco Pharma revenue growth forecast
Expected growth rate Q1, FY2027:
Forecast
Actual
Including amortisation and stock based compensations
Natco Pharma EPS growth forecast
EPS estimate Q1, FY2027:
Forecast
Actual
Source: S&P Global Market Intelligence
Natco Pharma Ltd Financial Results
Get the annual and quarterly financial summary of Natco Pharma Ltd, including revenue, profit, loss and more.
Natco Pharma Earnings and Dividends
View detailed summary of the earnings and dividend history of Natco Pharma.
Natco Pharma Ltd Earnings Results
Natco Pharma Ltd’s net profit fell -28.09% since last year same period to ₹480.70Cr in the Q1 2025-2026. On a quarterly growth basis, Natco Pharma Ltd has generated 18.22% jump in its net profits since last 3-months.
Read More about Earnings ResultsNatco Pharma Ltd Dividends August,2025
In the quarter ending June 2025, Natco Pharma Ltd has declared dividend of ₹2.00 per share on 12 Aug 2025 - translating a dividend yield of 0.91%.
Read More about Dividends
Indices Featuring Natco Pharma Stock
Check stock indices that include Natco Pharma.
Natco Pharma Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Natco Pharma.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 49.56% | 0.00 | |
| Foreign Institutions | 15.51% | ||
| Mutual Funds | 2.11% | 14.12 | |
| Retail Investors | 29.11% | 6.66 | |
| Others | 3.7% |
Natco Pharma Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Natco Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| HOLD | 15,318.37 | 1.07% | 0.54 | 1,388 | 3,998 | |
| BUY | 11,754.51 | -8.25% | 0.52 | 413 | 2,013 | |
| BUY | 61,265.74 | 3.86% | 0.60 | 3,483 | 31,723 | |
| HOLD | 99,400.82 | 30.78% | 0.61 | 4,614 | 23,241 | |
| BUY | 67,755.63 | 17.37% | 0.00 | 1,414 | 6,445 |
Natco Pharma News & Key Events
Latest news and events in one place to help you make informed investing decisions in Natco Pharma.
Natco Pharma Launches Bosentan Amidst Stock Decline - 20 Aug, 2025
Natco Pharma launched Bosentan tablets for pulmonary arterial hypertension in the U.S., securing first-to-file status and 180-day exclusivity. However, shares declined 1% despite the announcement.Natco Pharma Discusses Tariff Impact and Dividend Declaration - 19 Aug, 2025
Natco Pharma's CEO addressed potential U.S. tariff disruptions and the company's diversification strategy. Additionally, an interim dividend of Rs. 2 per share was declared for FY 2025-26.Natco Pharma Reports Decline and Declares Dividend - 12 Aug, 2025
Natco Pharma's Q1 results show a 28% decline in net profit to ₹480 crore due to pricing pressures and R&D costs. The company declared an interim dividend of ₹2 per share.Natco Pharma Expands with Adcock Acquisition and FDA Approval - 24 Jul, 2025
Natco Pharma aims to diversify by acquiring a 35.75% stake in Adcock Ingram for Rs 2,000 crore. Additionally, it received USFDA EIR for its Hyderabad API facility, reporting a 5.3% increase in Q4 FY25 net profit.Natco Pharma Moves to Acquire Stake in Adcock Ingram - 23 Jul, 2025
Natco Pharma has made a firm cash offer to acquire a 35.75% stake in South Africa's Adcock Ingram Holdings for ₹2,000 crore, aiming to strengthen its presence in the African market. The acquisition will consolidate Natco's previous stake and establish a new subsidiary in South Africa.
Insights on Natco Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 1.85% to 2.11% in Jun 2025 quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 27.29% to 29.11% in Jun 2025 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 133.0 Cr → 480.7 Cr (in ₹), with an average increase of 41.4% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 651.1 Cr → 1.39K Cr (in ₹), with an average increase of 28.4% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 49.56% of holdings in Jun 2025 quarter
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 133.9% return, outperforming this stock by 94.9%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 26.3% return, outperforming this stock by 71.6%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 17.49% to 15.51% in Jun 2025 quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, NATCOPHARM stock has moved down by -9.1%
About Natco Pharma Ltd
Revenue: ₹1,328.90Cr as on June 2025 (Q1 FY26)
Net Profit: ₹480.30Cr as on June 2025 (Q1 FY26)
Listing date: 27 Dec, 1995
Chairperson Name: G S Murthy
| Organisation | Natco Pharma Ltd |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| CEO | G S Murthy |
| E-voting on shares | Click here to vote |
Mutual Funds that own Natco Pharma Stock
Check out the Mutual Funds with significant holdings in Natco Pharma.
FAQs
What is Natco Pharma share price today?
Natco Pharma share price today stands at ₹855.25, Open: ₹874.95, Previous Close: ₹874.85, High: ₹875.35, Low: ₹853.6, 52 Week High: ₹1639, 52 Week Low: ₹726.8 as on .
How to buy Natco Pharma shares ?
To buy Natco Pharma shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for NATCOPHARM or Natco Pharma Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Natco Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Natco Pharma?
Today's traded volume of Natco Pharma is 3.80L. Which means that 3.80L shares of Natco Pharma were bought and sold on the stock market during today's trading session.
What is Natco Pharma's market cap today?
Today's market capitalisation of Natco Pharma is ₹15,318.37 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Natco Pharma?
Natco Pharma’s 52 week high is ₹1639 and 52 week low is ₹726.8. The current share price of Natco Pharma is ₹855.25, which is -47.82% down from its 52 week high and 17.67% up from its 52 week low.